Dupilumab Outcomes Stable in Open-Label AD Study Dupilumab Outcomes Stable in Open-Label AD Study

Other recent research on the biologic has shown that it improves lesional skin barrier function and rapidly reduces the abundance of Staphylococcus aureus on lesional skin.MDedge News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Dermatology News Source Type: news